Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
NCT07034131 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2025-07-01
Summary
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.
Conditions
- Osteoporosis Risk
- Osteoporosis, Postmenopausal
Interventions
- OTHER
-
Osteo-Buddy
Osteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with: 1. Evaluating their risk level of osteoporosis 2. Recommending screening and referrals 3. Lifestyle interventions through motivation, education and tailored guidance As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data.
- OTHER
-
Usual Care
Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'
Sponsors & Collaborators
-
SingHealth Polyclinics
lead OTHER
Principal Investigators
-
Eunice Lim · SingHealth Polyclinics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-31
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
More Related Trials
-
Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)
NCT01011725 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
NCT01803607 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
NCT01343004 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)
NCT00770159 ·Status: COMPLETED ·Phase: PHASE1
-
STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)
NCT00583518 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk
NCT04128163 ·Status: UNKNOWN ·Phase: PHASE3
-
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
NCT00354302 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
NCT00383422 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)
NCT00729183 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
NCT01552122 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)
NCT00885170 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
NCT04757376 ·Status: COMPLETED ·Phase: PHASE3
-
HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.
NCT00376662 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
NCT00769418 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer
NCT03324932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
NCT06154187 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Secondary Prevention of Osteoporosis
NCT00421343 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid
NCT00745485 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
NCT04512872 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
NCT00542425 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
NCT00293813 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Odanacatib (0822-059)
NCT01068262 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)
NCT00620113 ·Status: COMPLETED ·Phase: PHASE2
-
3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
NCT00310531 ·Status: COMPLETED ·Phase: PHASE3
-
Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy
NCT04861142 ·Status: UNKNOWN